UniProtKB/SwissProt variant VAR

Variant information

Variant position:

899

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LP/P [Disclaimer]

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Isoleucine (I) to Threonine (T) at position 899 (I899T, p.Ile899Thr).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from medium size and hydrophobic (I) to medium size and polar (T)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

-1

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

In AIS.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs1555998105 [ dbSNP | Ensembl ]

Sequence information

Variant position:

899

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

920

The length of the canonical sequence.

Location on the sequence:

FDLLIKSHMVSVDFPEMMAE I ISVQVPKILSGKVKPIYFHT

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         FDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHT

                              FDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHT

Rhesus macaque                FDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHT

Chimpanzee                    FDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHT

Mouse                         FDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHT

Rat                           FDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHT

Pig                           FDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHT

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 920	Androgen receptor
Domain	669 – 900	NR LBD
Region	552 – 919	Interaction with LPXN
Region	592 – 919	Interaction with CCAR1
Region	625 – 919	Interaction with KAT7
Site	898 – 898	Interaction with coactivator FXXLF and FXXFY motifs
Modified residue	916 – 916	Phosphotyrosine; by CSK
Alternative sequence	645 – 920	Missing. In isoform 3.
Alternative sequence	649 – 920	Missing. In isoform 4.
Mutagenesis	898 – 898	E -> AQ. Reduced transcription activation in the presence of androgen.
Mutagenesis	898 – 898	E -> KR. Loss of transcription activation in the presence of androgen.
Mutagenesis	916 – 916	Y -> F. Decrease in CSK-induced phosphorylation.
Helix	894 – 902

Literature citations

No reference for the current variant in UniProtKB/Swiss-Prot.

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P10275: Variant p.Ile899Thr